‘Too early’ to say how Purdue Pharma deal will impact Baton Rouge opioid lawsuit

    Purdue Pharma, the maker of OxyContin, has filed for bankruptcy as part of a planned $10 billion agreement to settle thousands of lawsuits over its role in the nation’s opioid crisis. But it’s …

    Already an INSIDER? Sign in.

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.